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In respiratory diseases such as CF, the small airways are the major site of
airway epithelium injury and remodelling. The bronchiolar epithelium has then
to rapidly regenerate its structure. The aim of our study was to characterize
the sequence of events leading to human bronchiolar epithelium reconstitution.
Bronchioles were microdissected from lung samples and processed for epithelial
cell dissociation. Bronchiolar epithelial cells (BECs) were cultured at the air-liquid
interface, and cultures were collected at different steps of the regeneration process
for characterization of epithelial cell polarization, differentiation and functionality.
Our results demonstrated that, at day 6, BECs formed a polarized monolayer
expressing intercellular junction proteins. BECs started to differentiate at day 15,
and at day 25, the cultures were well-differentiated and composed of basal, ciliated,
goblet and Clara cells. The Ussing chamber technique showed that cAMP-induced
chloride efﬂuxes were detected at, and increased from the step of ciliated cells
appearance (day 15) whereas CFTR mRNAs were expressed as early as day 5.
Finally, the ability of BECs to kill S. aureus was increasing during the course of
regeneration, and in the well-differentiated cultures the ciliary beating frequency
was similar to that measured for native bronchiolar epithelium sheets. In conclusion,
we have developed an in vitro model allowing to reconstitute a fully mature
and functional human bronchiolar epithelium. This model represents a tool for
the analysis of the molecular events associated with CF and non CF bronchiolar
epithelium regeneration.
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Airway submucosal glands produce most of airway mucus which is essential
for mucociliary clearance and also protect airway from bacteria by secretion of
antimicrobial components. Adequate mucus secretion from airway submucosal
glands is essential for maintaining airway defense. In contrast, defective mucus
secretion could result in chronic airway infection which could be the pathogenesis
of cystic ﬁbrosis. And overproduction of secretion from airway gland also leads
airway disease such as chronic obstructive lung disease and asthma. However the
exact mechanism of mucus secretion from airway submucosal glands by local reﬂex
is still unclear.
The G-protein-coupled protease-activated receptors (PARs) are activated by pro-
teolytic cleavage of the N-terminal extracellular domain, leading to cytosolic
Ca2+ elevation. Endogenous PAR activators such as mast cell tryptase, neutrophil
proteinase 3, and membrane-type serine protease-1 have been reported in airway.
More interestingly, exogenous activators containing protease, such as house dust
mite or bacteria can activate PAR-2 and stimulate release of pro-inﬂammatory
cytokines in human lung epithelial cells, thus PAR-2 appear to be involved in
local inﬂammation and innate immune response.
Previous studies suggest that PARs can regulate anion and ﬂuid secretion in airway
epithelia. However, there is no evidence that PAR involved in mucus secretion from
airway submucosal glands.
In this study, we showed that activation of PAR-2 in human airway glands induced
mucus secretion and also found the mechanism of PAR-2 induced mucus secretion
in porcine airway glands.
67* The effects of bacterial stimulation on prostasin levels within the
cystic ﬁbrosis lung
K.L. Mofﬁtt1, G.G. Einarsson1, B. Walker1, J.S. Elborn2, S.L. Martin1. 1Queen’s
University Belfast, School of Pharmacy, Belfast, United Kingdom; 2Belfast City
Hospital, Regional Adult CF Unit, Belfast, United Kingdom
CF pathogenesis is characterised by persistent, chronic bacterial infection and
inﬂammation of the airways. Evidence exists that abnormal regulation of airway
epithelial sodium channels (ENaCs) initiates a decrease in surface liquid which
contributes to the development of chronic bacterial infection through the build
up of mucus. ENaCs are activated by Channel Activating Proteases (CAPs) whose
inhibition blocks sodium adsorption, thus re-establishing airway hydration. Prostasin
has been established as being a CAP.
The aims of this study were to establish prostasin levels in CF and non-CF bronchial
epithelial cells and to observe whether this level was affected by stimulation with
CF-associated pathogens.
CFBE and HBE cells were challenged for 24 hours with bacterial supernatants/
heat inactivated whole cell lysates from strains of Burkholderia cenocepacia,
B. multivorans and P. aeruginosa. Conditioned media was assayed for prostasin
activity using the ﬂuorogenic substrate BOC-QAR-AMC. Activity was veriﬁed by
Western blotting with an anti-human prostasin antibody.
CFBE cells inherently demonstrated increased prostasin activity compared to HBE
cells (p = 0.02). Following stimulation with bacterial species, prostasin levels in
CFBE decreased to a signiﬁcant level with all strains, with the exception of P. aerug-
inosa which initiated an increased response. Conversely, following stimulation by
all bacterial species, increased prostasin activity was observed by HBE cells.
Proteolytic processing of ENaCs regulates Na+ and ASL absorption across the
airway surface epithelium and as such, has potential clinical importance in addition
to being a therapeutic target.
68 Citrate’s effects on airway ion transport differ from other calcium
chelators and dicarboxylic acids
P.G. Middleton1, H.H. House1. 1Westmead Millenium Institute, Respiratory
Mediicine, Sydney, NSW, Australia
Introduction: The ion transport abnormalities in the CF airway can be demonstrated
in vivo using the nasal potential difference (PD) technique. We have previously
shown that the CF airway can develop a small response to amiloride/low Cl−
solution when the surface is nominally Ca2+ free (Am J Respir Crit Care Med
2003; 168: 1223), and that citrate further augments this effect. To delineate the
possible mechanisms involved in the citrate response, we have examined the effect
of EGTA, EDTA, oxalate, succinate, and fumarate on nasal PD.
Methods: Nasal PD was measured in groups of CF and non-CF subjects to compare
the different calcium chelators and dicarboxylic acids, in the presence and absence
of amiloride/low Cl− pretreatment.
Results: Citrate decreased basal NPD by 2mV, but in the presence of amiloride/
low Cl− solution, citrate increased PD by 5.3mV in the non-CF and 3.1mV in
the CF subjects. Succinate showed a non-signiﬁcant trend to increase PD by 2mV;
oxalate, fumarate, EDTA and EGTA were all without effect.
Conclusion: The combination of these responses suggests that citrate exerts
complex effects on airway ion transport, through mechanisms other than calcium
chelation.
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